| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |